(PharmaNewsWire.Com, February 10, 2017 ) The Healthcare practice at MarketsandMarkets is pleased to announce its Webinar on the "In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021", to be held on 10th Feb, 2017
One of the major challenges faced by the healthcare industry is the growing burden of cancer worldwide. Cancer has profound social and economic consequences for people globally, and in situ hybridization has emerged as a powerful molecular tool for cancer diagnosis and treatment. The technique uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in situ) fixed on a slide. Increasing diagnosis and growing prevalence of cancer, technological advancements in therapeutics, and increasing government initiatives globally are some of the pivotal factors triggering the growth of the market.
MarketsandMarkets is delighted to invite you to an event titled "In Situ Hybridization: A Promising Adjunct to Immunohistochemistry" will be organized on February 10, 2017 from 09:00 am to 09:30 am CST. Join our experts as they speak about In-Situ Hybridization Market and its future prospects.
Specific Insights:
How has the in situ hybridization technique evolved? What are the major market trends? Technological advancements Regional analysis What are the roadblocks to adoption of this technique? What are the growth strategies adopted by players to gain a competitive edge in this market?
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
